Disease management: Remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors

Europace

Volumn 15, Issue SUPPL.1, 2013, Pages

  Abraham, William T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MONITOR; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; HEART FAILURE; HEART LEFT ATRIUM PRESSURE; HEART RATE VARIABILITY; HEART RIGHT VENTRICLE PRESSURE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; IMPEDANCE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERACTIVE VOICE RESPONSE SYSTEM; LUNG ARTERY PRESSURE; MONITORING; PARASYMPATHETIC TONE; PATIENT MONITORING; PHYSICIAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMOTE MONITORING; RISK ASSESSMENT; SELF CARE; TELEMONITORING; TREATMENT OUTCOME;

BLOOD PRESSURE MONITORING, AMBULATORY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY, AMBULATORY; HEART FAILURE; HUMANS; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84878907294     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut105     Document Type: Article

References (29)

1. Jencks SF, WilliamsMV, Coleman EA. Rehospitalizationsamong patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-28.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 2011;123:e18-209. 2010 Dec 15.
3. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683-94.
4. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z et al. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301-9.
5. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: The telemedical interventional monitoring in Heart Failure Study. Circulation 2011;123:1873-80.
6. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
8. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure.NEngl J Med 2005;352:1539-49.
9. Linde C, AbrahamWT, Gold MR, St John Sutton M, Ghio S, Daubert C et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-43.
10. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
11. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-95.
12. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289: 2685-94.
13. Chung ES, Katra RP, Ghio S, Bax J, Gerritse B, Hilpisch K et al. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction .35%: A PROSPECT trial substudy. Eur J Heart Fail 2010;12:581-7.
14. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of theAmerican College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [corrected]. Circulation 2012;126:1784-800.
15. Sarkar S, Koehler J, CrossleyGH, TangWH,AbrahamWT,WarmanENet al. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization. Am Heart J 2012;164:616-24.
16. Yu CM,Wang L, Chau E, Chan RH, Kong SL, TangMOet al. Intrathoracic impedance monitoring in patients with heart failure: Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-8.
17. Ypenburg C, Bax JJ, van derWall EE, Schalij MJ, van Erven L. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 2007;99:554-7.
18. AbrahamWT, Compton S, Haas G, Foreman B, Canby RC, Fishel R et al. FAST Study Investigators. Congest Heart Fail 2011;17:51-5.
19. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G et al. DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011;124:1719-26.
20. Adamson PB, Smith AL, Abraham WT, Kleckner KJ, Stadler RW, Shih A et al. Continuous autonomic assessment in patients with symptomatic heart failure: Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004;110:2389-94.
21. Whellan DJ, Ousdigian KT, Al-Khatib SM, PuW, Sarkar S, Porter CB et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010;55:1803-10.
22. ReynoldsDW, Bartelt N, Taepke R, Bennett TD. Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 1995;25:1176-82.
23. Adamson PB, Magalski A, Braunschweig F, Böhm M, Reynolds D, Steinhaus D et al. Ongoing right ventricular hemodynamics in heart failure: Clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003;41: 565-71.
24. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study. J Am Coll Cardiol 2008;51:1073-9.
25. Adamson PB, Abraham WT, Aaron M, Aranda JM Jr, Bourge RC, Smith A et al. CHAMPION trial rationale and design: The long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail 2011;17:3-10.
26. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW et al. for the CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet 2011;377:658-66.
27. Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN et al. Direct left atrial pressure monitoring in ambulatory heart failure patients: Initial experience with a new permanent implantable device. Circulation 2007;116:2952-9.
28. Troughton RW, Ritzema J, Eigler NL, Melton IC, Krum H, Adamson PB et al. Direct left atrial pressure monitoring in severe heart failure: Long-term sensor performance. J Cardiovasc Transl Res 2011;4:3-13.
29. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H et al. Physiciandirected patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 2010;121:1086-95.